Phase i study of ficlatuzumab and cetuximab in cetuximab-resistant, recurrent/metastatic head and neck cancer

Julie E. Bauman, James Ohr, William E. Gooding, Robert L. Ferris, Umamaheswar Duvvuri, Seungwon Kim, Jonas T. Johnson, Adam C. Soloff, Gerald Wallweber, John Winslow, Autumn Gaither-Davis, Jennifer R. Grandis, Laura P. Stabile

Research output: Contribution to journal › Article › peer-review